40 slide grand rounds presentation about enteropathic arthrtis. The first 5 slide should describe enteropathic arthritis (SpA-IBD), including demographics in crohns vs UC and typical symptoms. 1 slide should compare Type I and II EA. 1 slide should describe the pathogenesis of the arthritis. Next, 2 slides describging treatment, either with conventional DMARDS or biologics. differentiate between axial and peripheral symptoms. Emphasize the fact that there are no specific guidelines for EA. Next, 1 slide should show all of the different outcomes measures used in spondyloarthritis research including ASDAS, BASDAI, etc. Then I will present all of the available safety data on dual biologics in IBD and why they are proabbly safe to be using in our arhtriits patietns. Finally, I will present my retrospective research on patients taking vedolizumab who develop enteropathic artritis and how they have been treated at our institution.
40 slide grand rounds presentation about enteropathic arthrtis. The first 5 slide should describe enteropathic arthritis (SpA-IBD), including demographics in crohns vs UC and typical symptoms. 1 slide should compare Type I and II EA. 1 slide should describe the pathogenesis of the arthritis. Next, 2 slides describging treatment, either with conventional DMARDS or biologics. differentiate between axial and peripheral symptoms. Emphasize the fact that there are no specific guidelines for EA. Next, 1 slide should show all of the different outcomes measures used in spondyloarthritis research including ASDAS, BASDAI, etc. Then I will present all of the available safety data on dual biologics in IBD and why they are proabbly safe to be using in our arhtriits patietns. Finally, I will present my retrospective research on patients taking vedolizumab who develop enteropathic artritis and how they have been treated at our institution.
Created using ChatSlide
The Enteropathic Arthritis Grand Rounds focus on the intersection of spondyloarthritis (SpA) and inflammatory bowel disease (IBD), emphasizing the need for early recognition and coordinated management of gut and joint symptoms. The session covers the clinical spectrum of enteropathic arthritis, epidemiological differences between Crohn's disease and ulcerative colitis, and the importance of recognizing symptom patterns. It discusses treatment strategies, including conventional therapies and...